On July 27, Regeneron Pharmaceuticals rose 3.08% in regular trading, trading at $676.44 USD/share, with Turnover of $98.2253 million.
Within the Biotechnology sector where Regeneron Pharmaceuticals belongs, the overall sector showed broad strength. Among individual stocks, Forte BioSciences Inc up 39.55%, Entera Bio Ltd. up 93.66%, Vertex Pharmaceuticals up 1.7%, Gilead Sciences up 2.64%, AbbVie up 0.68%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)